CIK 0001501989
- Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273521219
- Phone
- +1 650-515-3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 4 Grant or award General Counsel acquired 1,812 shares (grant or award)
- 4 Grant or award Principal Accounting Officer acquired 1,812 shares (grant or award)
- 4 Grant or award President and CEO acquired 695 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4/A Gift Director gave 3,900 shares (gift)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Gift Director gave 7,800 shares (gift)
- 4 Open-market buy General Counsel bought 9,000 shares at $10.33 ($92,970)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Financial Officer sold 3,000 shares at $15.00 ($45,000)
- 4 Grant or award President and CEO acquired 468 shares (grant or award)
- 4 Grant or award General Counsel acquired 979 shares (grant or award)
Page 11 of 20 · 400 filings